Actinium Newsroom

Maxim Group Maintains Actinium(ATNM.US) With Buy Rating, Announces Target Price $5

Moomoo NewsNov 20 13:31 ET

Actinium Pharma Analyst Ratings

BenzingaNov 19 12:54 ET

Stephens Maintains Actinium(ATNM.US) With Buy Rating, Cuts Target Price to $5

Moomoo NewsNov 19 12:31 ET

Actinium Pharma Analyst Ratings

BenzingaNov 15 14:15 ET

H.C. Wainwright Maintains Actinium(ATNM.US) With Buy Rating, Cuts Target Price to $4

Moomoo NewsNov 15 10:32 ET

B. Riley Downgrades Actinium Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $2 From $16

MT NewswiresAug 7 12:52 ET

Actinium Pharmaceuticals Price Target Cut to $4.00/Share From $50.00 by HC Wainwright & Co.

Dow JonesAug 6 15:05 ET

Maxim Group Maintains Actinium(ATNM.US) With Buy Rating

Moomoo NewsAug 6 13:32 ET

Actinium Pharma Analyst Ratings

BenzingaAug 6 10:42 ET

JonesTrading Maintains Actinium(ATNM.US) With Buy Rating, Cuts Target Price to $9

Moomoo NewsAug 5 15:31 ET

Actinium Pharma Analyst Ratings

BenzingaJul 26 07:45 ET

H.C. Wainwright Maintains Actinium(ATNM.US) With Buy Rating, Maintains Target Price $50

Moomoo NewsJul 26 06:33 ET

Actinium Pharma Analyst Ratings

BenzingaJun 17 10:45 ET

Analysts Are Bullish on Top Healthcare Stocks: Citius Pharmaceuticals (CTXR), Actinium Pharmaceuticals (ATNM)

TipRanksMay 22 14:05 ET

Actinium Pharma Analyst Ratings

BenzingaMay 21 06:52 ET

HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $50 Price Target

BenzingaMay 21 06:52 ET

Actinium Pharma Analyst Ratings

BenzingaMay 14 05:56 ET

Actinium Pharma Analyst Ratings

BenzingaMay 2 13:14 ET

Actinium Pharma Analyst Ratings

BenzingaApr 30 10:17 ET

Actinium Pharma Analyst Ratings

BenzingaApr 29 06:11 ET